Peptinov
PrivateLast Round
Grant
Jun 24, 2024
Total Funding Raised
$19.15M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Peptinov is a biotechnology company that develops innovative active immunotherapy treatments for chronic inflammatory diseases and cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Peptinov Comparables
Compare Peptinov with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neovacs | 80% | |
| 4Moving Biotech | 78% | |
| Biosplice Therapeutics | 68% |
Peptinov Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 24, 2024 | ||||
| Grant | Apr 23, 2024 | ||||
| Grant | Oct 1, 2023 | ||||
| Accelerator | Oct 1, 2023 | ||||
| Venture - Series Unknown | May 23, 2023 | ||||
VC Round | Mar 1, 2023 |
Key People
Founding team and executive leadership
Peptinov Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Happy Capital | Seed, VC Round |
| Les Business Angels des Grandes Écoles | Angel, VC Round |
| European Innovation Council Fund | Grant, Accelerator |
| Groupe IRCEM | VC Round |
| WiSeed | Seed |
| Bpifrance | Grant |
| IRCEM Prévoyance | Venture - Series Unknown, Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 40% MoM.
- Mar 1, 2023
$5M raised led by Groupe IRCEM and IRCEM Prévoyance.
Peptinov Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Peptinov's valuation, stock price, and market status.
Is Peptinov a public or private company?
Peptinov is a private company.
What is the current stock price of Peptinov?
Peptinov is a private company, so its shares have no public market price. Caplight tracks Peptinov's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Peptinov worth (valuation)?
Valuation information for Peptinov is not publicly available.
Can I buy Peptinov stock?
Peptinov shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Peptinov's last funding round?
Peptinov's most recent funding round was Grant on June 24, 2024.
Who are the main investors in Peptinov?
Key investors in Peptinov include European Innovation Council Fund, Groupe IRCEM, Bpifrance, IRCEM Prévoyance.
Will Peptinov IPO soon?
No public IPO plans have been announced for Peptinov.
How can I track Peptinov secondary market activity?
Caplight tracks bids, offers, and trades in Peptinov's shares on secondary markets.